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A best evidence topic in vascular surgery was written according to a structured protocol. The question
addressed whether endovascular treatment improved peri-operative outcomes when compared to an
open approach to restore arterial perfusion in acute mesenteric occlusive disease. Four hundred and
ninety seven papers were identiﬁed using the reported search; of which 4 represented the best evidence
to answer the question and are discussed. The evidence on this subject is limited, comprising largely of
non-randomised retrospective cohort studies. The evidence suggests that endovascular treatment is
associated with reduced mortality and has better short-term peri-operative outcomes, as well as longer-
term survival e however many endovascular cases require subsequent open surgery. There is also
conﬂicting evidence to suggest endovascular therapy is associated with longer ICU stays. Aside from
procedural complications, factors such as patient status, time delay to diagnosis and treatment may play
a greater role in determining mortality rates. In summary, endovascular therapy appears to be a feasible
treatment option with post-operative complications and inpatient mortality rates lower than those seen
in open surgery.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
A best evidence topic was constructed according to a structured
protocol. This is fully described in a previous publication in the
International Journal of Surgery.12. Clinical scenario
You have been called to see a 71-year old male who has been
diagnosed with acute mesenteric occlusive disease following a
diagnostic emergency mesenteric CT angiogram. Your colleague
recommends the patient undergo urgent revascularisation using
an endovascular treatment approach, stating “this approach has
been shown to have fewer post-operative complications and
lower mortality rates compared to traditional open surgery”. You
resolve to consult the literature to assess the evidence base for; fax: þ44 (0) 1603 286428.
lop).
ciates Ltd. Published by Elsevier Ltthe surgical management options of acute mesenteric occlusive
disease.
3. Three-part question
In patients who require treatment to restore arterial perfusion in
acute mesenteric occlusive disease, does an endovascular approach
as compared to an open approach improve clinical outcomes,
including morbidity and mortality?
4. Search strategy
Medline search 2000e2013 using the PubMed interface for the
terms: Search (((((((open surgery) AND endovascular) AND acute
mesenteric occlusive disease) OR acute mesenteric occlusion) OR
acute mesenteric ischaemia) OR acute mesenteric ischaemia) OR
acute mesenteric ischaemic disease) OR acute mesenteric ischae-
mic disease NOTchronic) NOT CT) NOTcardiac) NOTcoronary) AND
Humans[Filter]).
In addition, the reference lists of the relevant papers were
searched. The search was current as of 12th February 2013.d. All rights reserved.
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REVIEW5. Search outcome
In total, 497 papers were found using the reported search. From
these, 114 were not in English and were excluded. There were 31
articles directly relevant to the question asked e of these, 7 were
general articles focussing on the pathophysiology of acute mesen-
teric ischaemia, 5 were articles detailing surgical techniques, 2
described the aetiology of disease, 5 were case studies and there
was 1 opinion-based article. 4 papers either directly compared
clinical outcomes of open surgery and endovascular revascular-
isation in acute mesenteric occlusive disease or contained clinical
outcome data of one of the techniques. These papers were therefore
chosen as representing the best evidence to answer the clinical
question.
6. Results
The results of the 4 papers (4 retrospective cohort studies) are
summarised in Table 1.
7. Discussion
All of the four retrospective studies included in this review
compared mortality rates among patients who received endo-
vascular thrombolysis to those who underwent open emergency
laparotomy treatment. In a 2011 study, Arthurs et al.,2 (n ¼ 70)
found that inpatient mortality was signiﬁcantly lower when an
endovascular approach was used compared to an open approach
(36% vs. 50%; p < 0.05). Block et al.,3 also posited a lower 30-day
mortality rate with endovascular thrombolytic therapy compared
to open surgery (28% vs. 42%; p ¼ 0.03). Barakate et al.,4 pre-
sented a small-scale study (n ¼ 8) which found that inpatient
mortality was 57% among patients who underwent open surgery
to treat superior mesenteric artery (SMA) occlusion, vs. no mor-
tality for endovascular repair. However, in 2012, Ryer et al.,5
presented a retrospective cohort study of 93 patients with acute
mesenteric ischaemia which failed to establish a signiﬁcant dif-
ference in clinical outcomes between open and endovascular
revascularisation.
Various factors should be considered when forming conclusions
from these results. Firstly, the clinical diagnosis of acute mesenteric
ischaemia is, arguably, not clear-cut. At present, diagnosis of acute
mesenteric ischaemia is primarily based on clinical presentation
and radiographic ﬁndings (CT angiography). Whilst some studies
suggest there are highly sensitive and speciﬁc plasma biomarkers
for acute mesenteric ischaemia in humans (e.g. I-FABP: 100%
Sensitivity, 96% Speciﬁcity e Kanda, 19966), these biomarkers are
not used for deﬁnitive diagnosis as the evidence is controversial
(Block et al., 2008 suggests plasma biomarkers I-FABP, a-gluta-
thione S-transferase, D-lactate and creatine kinase B, do not differ
amongst AMI patients and controls). The clinical presentation of
acute mesenteric ischaemia differs from that of a chronic mesen-
teric ischaemia (CMI), with patients of the former often presenting
with sudden onset of severe abdominal pain, whilst the latter
complain of ongoing symptoms including post-prandial abdominal
pain and subsequent weight loss. Usually in CMI, the development
of a collateral circulation prevents infarction occurring. However
CMI patients with advanced disease could potentially present in an
identical manner to AMI patients, where either thrombosis or
embolus occurs in a narrowed artery. These patients with “acute on
chronic” mesenteric ischaemia could therefore be misclassiﬁed as
AMI patients in the studies considered in this review. It has been
established that CMI patients who undergo open procedures
develop increased rates of complications peri-operatively than
endovascular revascularisation.7 Of the 4 studies, Arthurs et al.2excluded patients “presenting with AMI secondary to mesenteric
venous thrombosis, non-occlusive mesenteric ischaemia, aortic
dissection complicated by visceral ischaemia due to investigational
device exemption protocol”. Similarly, Barakate et al. only included
patients with ischaemia due to acute SMA occlusion (based upon CT
scanning, angiography or operative ﬁndings) and Ryer et al. stated
that patients with “sub-AMI were excluded from the analysis”.
Interestingly, Ryer et al. reported that approximately 40% of their
patients had symptoms suggestive of chronic mesenteric insufﬁ-
ciency (which corresponded to more than 40% of their patients
having necrotic bowel at their initial laparotomy). Block et al.3 took
a different approach, including patients with symptoms of previous
chronic mesenteric ischaemia if they presented with an acute onset
of intestinal ischaemia.
Secondly, mortality outcomes vary amongst the studies dis-
cussed, whilst Block and Ryer described thirty-day mortality, Ar-
thurs and Barakate described inpatient mortality (Arthurs do not
discuss the length of inpatient stay before discharge, but the pa-
tients who survived in Barakate’s study were discharged between 9
and 28 days).
Thirdly, one must consider that there are inherent difﬁculties in
studying management of AMI patients. The cohort sizes in the
studies discussed are generally very small, the investigators being
limited by the low incidence of AMI. This particularly limits the
reliability of conclusions based on mortality rates from Barakate’s
study, which included 7 patients who underwent open treatment
and just 1 who underwent endovascular thrombolysis. In addition,
again due to the low incidence of the disease, often the study period
may last several years or even decades. As such, the usefulness of
such a study might be questionable given improvements in treat-
ment protocols with time (particularly so for endovascular
thrombolysis). This is exempliﬁed in Ryer’s retrospective study
which followed 93 patients presenting with AMI between 1990 and
2010, which reveals an improvement in overall thirty-daymortality
rates from 27% in 1990s to 17% in 2000s (with no signiﬁcant dif-
ference between open and endovascular revascularisation).
Whilst the question of interest in this review is a direct com-
parison of laparotomy to an endovascular approach, there are
inherent difﬁculties in interpreting the clinical outcomes due to
issues of selection bias and problems in clearly delineating the
management options described. Due to the design of Arthurs’
study, cohorts were non-randomised and therefore open to selec-
tion bias e deteriorating patients were more likely to be managed
by an open approach (and hence, arguably, have worse outcomes
due to a worse clinical starting point). The retrospective studies
often include patients who have undergone both approaches (i.e.
endovascular therapy followed by laparotomy), which makes it
difﬁcult to analyse the data on a scale larger than an individual
patient basis. In Arthurs study, 69% of those who underwent
endovascular treatment subsequently required a laparotomy (these
patients showed signs of peritoneal inﬂammation or clinical dete-
rioration following revascularisation) e arguably, some might ﬁnd
it difﬁcult to therefore see the beneﬁt of endovascular treatment.
However, for those patients who underwent endovascular treat-
ment with subsequent conversion to an open approach, themedian
lengths of necrotic bowel resectedwere signiﬁcantly shorter (52 cm
vs. 160 cm; p < 0.05), in patients who had been treated with
endovascular therapy prior to open surgery.
Peri-operative morbidity is a major consideration when making
clinical judgements for the management of AMI patients. In Ar-
thurs2 study, they noted that complications such as acute renal
failure (50% vs. 27%; p < 0.05) and respiratory failure (64% vs. 27%;
p < 0.05) were signiﬁcantly lower in patients treated with an
endovascular approach surgery reducing the likelihood of post-
operative short bowel syndrome.
Table 1
Best evidence papers.
Author, date
and country
Patient group Study type and
level of evidence
Outcomes Key results Comments
Arthurs
et al., 20112
USA
70 patients with acute mesenteric
ischaemia presenting between
1999 and 2008 (mean age,
64  13 years).
Aetiology: thrombotic 65%,
embolic 35%.
Endovascular revascularisation
was the preferred treatment
(81%) vs. operative therapy (19%).
Level III
retrospective
cohort study
Survival (Open surgery
vs. Endovascular)
Inpatient mortality: 50% vs. 36% (p < 0.05)
Mortality of endovascular failures: 50%
Endovascular therapy associated
with improved mortality in thrombotic
AMI (OR 0.10; 95% CI, 0.10e0.76; p < 0.05)
This study retrospectively evaluated the
outcomes of a cohort of patients who
underwent endovascular revascularisation
(81%) or operative therapy (19%) for treatment
of acute mesenteric ischaemia.
Successful endovascular treatment was achieved
in 87% of patients. However, laparotomy was
still necessary for 69% patients undergoing
endovascular therapy.
Endovascular therapy was associated with
reduced mortality rates, and improved clinical
outcomes.
The cohorts were non-randomised, there
may be confounding factors contributing to
the observed improved outcomes. It should be
noted that there is an inherent selection bias e
perhaps deteriorating patients are more likely
to be managed with an open approach
(and hence have worse outcomes) whilst
healthier patients were more likely to
receive endovascular therapy.
Other outcomes (Open surgery
vs. Endovascular)
Laparotomy requirement: 100% vs. 69%
(p < 0.05)
Median length of bowel resected
(if laparotomy required following
endovascular treatment): 160 cm vs. 52 cm
(p < 0.05)
Acute renal failure: 50% vs. 27% (p < 0.05)
Respiratory failure: 64% vs. 27% (p < 0.05)
Block
et al., 20103
Sweden
121 open and 42 endovascular
revascularisations of the SMA
at 28 hospitals between 1999
and 2006.
Level III
retrospective
cohort study
Survival (Open surgery vs.
endovascular thrombolytic
therapy)
Thirty-day mortality rate: 42% vs. 28%
(p ¼ 0.03)
1 year mortality rate:58% vs. 39% (p ¼ 0.02)
Long-term survival after endovascular
treatment was better than after open
surgery (log-rank, p ¼ 0.02).
This study provides good evidence that an
endovascular approach is associated with
lower mortality rates and better long-term
survival than an open operative approach
to treatment. This study was limited by the
lack of randomisation and selection bias
associated with retrospective studies.
Differences in outcome may have been
due to differences in disease severity,
the authors noted that CRP at admission
or time delay to intervention did not differ
between the groups.
Other outcomes Bowel resection (p < 0.001) and short
bowel syndrome (SBS; p ¼ 0.009) occurred
more frequently in the open group, and
these were independently associated with
increased long-term mortality.
Ryer
et al., 2012,5
USA
93 patients who underwent
arterial revascularisation for
acute mesenteric ischaemia
between January 1990 and
January 2010.
Level IV
Retrospective
cohort study
Survival (Open surgery
vs. Endovascular)
No signiﬁcant difference between open and
endovascular revascularisation.
Mortality (30-day): 27% (1990s) 17% (2000s)
Morbidity: Major adverse events occurred
in 47% of patients
This study compared management and outcomes
of acute mesenteric ischaemia over the past
2 decades. The study found no signiﬁcant
differences in clinical outcomes between open
and endovascular revascularisation.
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REVIEWWith regards to long-term survival, Block et al.,3 noted a
reduction in 1-year mortality rates (39% vs. 58%; p ¼ 0.02) and
improved long-term survival with endovascular treatment (log-
rank, p ¼ 0.02). Since the patients included in the study were non-
randomised, homogeneity between groups was analysed. Factors
including age, gender, delay to treatment, symptom onset, occur-
rence of vomiting, diarrhoea, haematochezia, risk factors (smoking,
cardiovascular disease, prior vascular surgery) were not signiﬁ-
cantly different between the 2 groups. However, patients who un-
derwent open surgery had a signiﬁcantly higher rate of atrial
ﬁbrillation (p ¼ 0.031) and a signiﬁcantly reduced subsequent
history of abdominal angina (p¼ 0.042) than thosewhowere in the
endovascular repair group. This could be a potential source of bias
in the outcomes reported. The authors noted that short bowel
syndrome (Hazard Ratio (HR), 2.6; 95% Conﬁdence Interval (CI),
1.3e5.0; p ¼ 0.005) and age (HR, 1.03/year; 95% CI, 1.00e1.06;
p ¼ 0.039) were predictors of decreased long-term survival.
Furthermore, Ryer et al.,4 presented predictors of late mortality
(>30 days from initial surgery) upon multivariate analysis included
age (HR,1.06; 95% CI,1.01e1.11; p¼ 0.015), connective tissue disease
(HR, 4.92; 95% CI, 1.19e20.21; p ¼ 0.03), and having a major post-
operative complication (HR, 5.25; 95% I, 1.88e14.67; p ¼ 0.0015).
In the study by Barakate et al.,4 the patient who received
endovascular thrombolysis was an 84-year old male who presented
with a history of 12-h of periumbilical pain, nausea, and co-morbid
atrial ﬁbrillation. Whilst this patient was not overtly young or
healthy, it could be argued that he presented with a less severe
form of the disease (i.e. no vomiting/diarrhoea). Usually emptying
of the gut by vomiting and/or diarrhoea is the result of bowel wall
spasm following bowel wall hypoxia. It should also be noted that
the patient who underwent endovascular treatment required a
longer stay in intensive care (15 days total) than the 3 patients who
survived open repair (ICU stays required by 2 of the 3 patients,
lasting 6 and 8 days respectively).
8. Clinical bottom line
As acute mesenteric occlusive disease is a rare conditionwith an
overall prevalence of 0.1% of all hospital admissions, there have
been no large-scale high quality studies on this topic and other
factors such as time to diagnosis and treatment may play an
important role in determining mortality rates. From the data
available, the best evidence suggests that endovascular therapy is a
feasible treatment option with post-operative complications and
inpatient mortality rates lower than those seen in open surgery,
however many endovascular cases require subsequent open sur-
gery. However, there is also conﬂicting evidence to suggest endo-
vascular therapy is associated with longer ICU stays. There may be a
role for endovascular thrombolysis prior to open surgery to reduce
the length of bowel resected. These conclusions are limited by the
small size of the studies and difﬁculties in differentiating acute
from acute-on-chronic presentation. Aside from procedural com-
plications, factors such as patient status, time delay to diagnosis
and treatment may play a greater role in determining mortality
rates. Therefore, until further evidence is available, it would seem
sensible to decide management on a case-by-case basis.
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